These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

55 related items for PubMed ID: 6114495

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Inhibition of prolactin secretion by lergotrile mesylate: mechanism of action.
    Clemens JA, Smalstig EB, Shaar CJ.
    Acta Endocrinol (Copenh); 1975 Jun; 79(2):230-7. PubMed ID: 166535
    [Abstract] [Full Text] [Related]

  • 4. Morphine can stimulate prolactin release independent of a dopaminergic mechanism.
    Shin SH, Obonsawin MC, Van Vugt DA, Baby N, Jhamandas K.
    Can J Physiol Pharmacol; 1988 Nov; 66(11):1381-5. PubMed ID: 2907416
    [Abstract] [Full Text] [Related]

  • 5. The interaction of dopaminergic and serotonergic drugs on plasma prolactin in ovariectomized, estrogen-treated rats.
    Lawson DM, Gala RR.
    Endocrinology; 1976 Jan; 98(1):42-7. PubMed ID: 1248448
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Possible involvement of dopamine in the release of prolactin-like hormone from bullfrog pituitary gland.
    Kikuyama S, Seki T.
    Gen Comp Endocrinol; 1980 Jun; 41(2):173-9. PubMed ID: 6968286
    [No Abstract] [Full Text] [Related]

  • 9. Effect of methysergide and pimozide on apomorphine-induced growth hormone secretion in men.
    Lal S, Guyda H, Bikadoroff S.
    J Clin Endocrinol Metab; 1977 Apr; 44(4):766-70. PubMed ID: 849986
    [Abstract] [Full Text] [Related]

  • 10. Comparative study of the effects of lisuride and pimozide on the preovulatory surge of FSH, LH and prolactin in rat.
    Kun I, Simionescu L, Oprescu M, Zamfir-Grigorescu D.
    Endocrinologie; 1984 Apr; 22(3):177-82. PubMed ID: 6436960
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effects of the dopamine agonist, lergotrile mesylate, on prolactin secretion in women.
    Leebaw W, Lee L, Woolf P.
    Acta Endocrinol (Copenh); 1978 Jan; 87(1):12-8. PubMed ID: 579527
    [No Abstract] [Full Text] [Related]

  • 15. Stereotyped responses of rats to two 2-halogenoergolines: 2-bromo-alpha-ergocryptine and lergotrile.
    Bergmann F.
    Isr J Med Sci; 1982 Jan; 18(1):177-82. PubMed ID: 6121772
    [Abstract] [Full Text] [Related]

  • 16. Dopamine agonistic potency of two novel prolactin release-inhibiting ergolines.
    Markó M.
    Eur J Pharmacol; 1984 Jun 01; 101(3-4):263-6. PubMed ID: 6468500
    [Abstract] [Full Text] [Related]

  • 17. A chronically hypoprolactinemic rat model: administration of lergotrile mesylate by osmotic minipump.
    Mills DE, Buckman MT, Peake GT.
    Proc Soc Exp Biol Med; 1981 Mar 01; 166(3):438-41. PubMed ID: 6111081
    [No Abstract] [Full Text] [Related]

  • 18. Studies on the antiparkinsonism efficacy of lergotrile.
    Lieberman A, Miyamoto T, Battista AF, Goldstein M.
    Neurology; 1975 May 01; 25(5):459-62. PubMed ID: 166332
    [Abstract] [Full Text] [Related]

  • 19. Dopaminergic mediation of beta-endorphin-induced prolactin secretion.
    Van Loon GR, De Souza EB, Shin SH.
    Neuroendocrinology; 1980 Oct 01; 31(4):293-6. PubMed ID: 6252497
    [Abstract] [Full Text] [Related]

  • 20. Metabolism of lergotrile to 13-hydroxy lergotrile, a potent inhibitor of prolactin release in vitro.
    Parli CJ, Schmidt B, Shaar CJ.
    Biochem Pharmacol; 1978 May 01; 27(9):1405-8. PubMed ID: 29651
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.